How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia
- PMID: 20144859
- DOI: 10.1016/j.drugpo.2009.11.004
How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia
Abstract
As countries in Asia strive to meet their universal access targets, harm-reduction programmes are yet to be scaled up to reach effective levels of coverage. Resource tracking and estimation of resource needs and gaps is critical to inform the financing decisions of major donors of harm-reduction programmes in the region. This study aimed at estimating the financial resource needs and gaps for scaling-up harm reduction in the region, building on previous research conducted by the Independent Commission on AIDS in Asia. The overall resource need for achieving universal access in the target population in 2009 was US $0.5 billion, with NSP and OST accounting for nearly 70% of the overall regional resource need. A significant resource gap, approximately 90%, of the resource need in 2009, was identified for harm reduction in the region, representing less than 2% of the overall global resource need to address AIDS. Additional resources will be required to support the introduction and scaling-up of integrated, comprehensive harm-reduction programmes that provide a full range of services to reduce HIV transmission among people who inject drugs.
Copyright (c) 2010. Published by Elsevier B.V.
Similar articles
-
Moving from a project to programmatic response: scaling up harm reduction in Asia.Int J Drug Policy. 2010 Mar;21(2):134-6. doi: 10.1016/j.drugpo.2009.12.004. Epub 2010 Jan 15. Int J Drug Policy. 2010. PMID: 20079618
-
HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.Int J Drug Policy. 2007 Oct;18(5):426-32. doi: 10.1016/j.drugpo.2007.01.011. Epub 2007 Feb 15. Int J Drug Policy. 2007. PMID: 17854732
-
The Global Fund's leadership on harm reduction: 2002-2009.Int J Drug Policy. 2010 Mar;21(2):103-6. doi: 10.1016/j.drugpo.2010.01.002. Epub 2010 Feb 19. Int J Drug Policy. 2010. PMID: 20171865
-
Injection drug use, HIV and the current response in selected low-income and middle-income countries.AIDS. 2010 Sep;24 Suppl 3:S20-9. doi: 10.1097/01.aids.0000390086.14941.91. AIDS. 2010. PMID: 20926924 Review.
-
Asia can afford universal access for AIDS prevention and treatment.AIDS. 2010 Sep;24 Suppl 3:S72-9. doi: 10.1097/01.aids.0000390092.53059.f1. AIDS. 2010. PMID: 20926931 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous